NTRA Natera, Inc. - Common Stock
$325,14
Precio · Ago 21, 2026
Fundamentales a fecha de Ago 7, 2026
Rango 52S
$157–$334
95% of range
Calificación del Analista
BUY
30 analysts
Precio Objetivo
$331
+2% upside
P/E (TTM)
-213.9
ROE
-14.1%
Margen de Beneficio Neto
-9.0%
Acerca de Natera, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
Leer más
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
NTRA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$325.14
Capitalización Bursátil
$45.42B
P/E (TTM)
-213.9
BPA (TTM)
$-1.52
Ingresos (TTM)
$2.31B
Rendimiento div.
—
ROE
-14.1%
Deuda/Capital
0.0
Rango 52S
$157 – $334
NTRA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2.31B
2016-12-31
→
2025-12-31
BPA
$-1.52
2016-12-31
→
2025-12-31
Flujo de caja libre
$109M
2016-12-31
→
2025-12-31
Márgenes
-9.0%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
NTRA
Mediana de Pares
P/E (TTM)
-213.9
17.7
P/S (TTM) (P/V (TTM))
19.7
6.8
P/B (P/C)
26.5
6.4
Price / FCF (Precio / FCF)
416.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
NTRA
Mediana de Pares
Operating Margin (Margen Operativo)
-13.4%
—
Net Profit Margin (Margen de Beneficio Neto)
-9.0%
20.3%
ROA
-10.3%
11.4%
ROE
-14.1%
16.8%
ROIC
-13.4%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
NTRA
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.0
—
Current Ratio (Ratio corriente)
3.4
3.4
Quick Ratio (Ratio Rápido)
0.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
NTRA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
35.9%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
41.1%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
42.6%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
NTRA
Mediana de Pares
NTRA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
30 analistas
- Compra fuerte 12 40,0%
- Compra 14 46,7%
- Mantener 4 13,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
21 analistas · 2026-08-17
Mediana
$348.00
Media
$330.64
Ahora
$325.14
Mín
$193.00
Máx
$375.00
Objetivo mediano
$348.00
+7,0%
Objetivo medio
$330.64
+1,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.11%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.47 | $-0.50 | 0.03% |
| 31 de marzo de 2026 | $-0.60 | $-0.55 | -0.05% |
| 31 de diciembre de 2025 | $0.36 | $-0.52 | 0.88% |
| 30 de septiembre de 2025 | $-0.64 | $-0.38 | -0.26% |
| 30 de junio de 2025 | $-0.74 | $-0.63 | -0.11% |
| 31 de marzo de 2025 | $-0.50 | $-0.65 | 0.15% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Balance general 28
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Flujo de Efectivo 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Balance general 26
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Valoración (TTM) 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.59B | $2.34B | · | $2.08B | $1.90B | $1.72B | · | $1.49B | $1.31B | $1.14B | · | $982M | $912M | $845M | · | $761M | |
| Net Income TTM | $-341M | $-341M | · | $-287M | $-237M | $-204M | · | $-246M | $-325M | $-424M | · | $-478M | $-514M | $-542M | · | $-556M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -110.8 | -80.6 | · | -75.2 | -93.9 | -87.3 | · | -61.3 | -39.0 | -24.7 | · | -10.1 | -9.8 | -10.2 | · | -7.5 | |
| P/S | 15.1 | 12.2 | · | 10.6 | 12.2 | 11.2 | · | 10.6 | 10.2 | 9.8 | · | 5.4 | 6.1 | 7.5 | · | 5.6 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| P / FCF | · | 1582.9 | · | · | · | 849.1 | · | · | · | 1672.1 | · | · | · | -68.0 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -31.9 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 5.0 | |
| Earnings Yield | -0.90% | -1.2% | · | -1.3% | -1.1% | -1.1% | · | -1.6% | -2.6% | -4.1% | · | -9.9% | -10.2% | -9.8% | · | -13.3% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Margen Operativo % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Beneficio neto | $-208M | $-190M | $-435M | $-548M | $-472M |
| EPS Diluido | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Ratio corriente | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Ratio Rápido | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $109M | $69M | $-286M | $-479M | $-376M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 935 declarantes · $20.5B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 165 (+55 vs trimestre anterior) | 63 (-36 vs trimestre anterior) | 347 (+42 vs trimestre anterior) | 250 (-6 vs trimestre anterior) | +14.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1 690 649 234 | 6 228 216 | 8,24% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 569 697 628 | 5 782 640 | 7,65% | Acciones |
| FMR LLC | $1 189 034 607 | 4 380 308 | 5,80% | Acciones |
| STATE STREET CORP | $992 317 506 | 3 655 618 | 4,84% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $965 965 683 | 3 558 540 | 4,71% | Acciones |
| Castle Hook Partners LP | $704 759 120 | 2 596 276 | 3,44% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $644 934 457 | 2 382 981 | 3,14% | Acciones |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602 175 451 | 2 218 366 | 2,94% | Acciones |
| NORGES BANK | $496 243 717 | 1 828 122 | 2,42% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $467 285 974 | 1 721 444 | 2,28% | Acciones |
| Sofinnova Investments, Inc. | $420 823 506 | 1 550 280 | 2,05% | Acciones |
| Capital World Investors | $408 365 851 | 1 504 387 | 1,99% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408 180 994 | 1 503 706 | 1,99% | Acciones |
| MAVERICK CAPITAL LTD | $368 266 171 | 1 356 663 | 1,80% | Acciones |
| D. E. Shaw & Co., Inc. | $322 096 327 | 1 186 577 | 1,57% | Acciones |
| GOLDMAN SACHS GROUP INC | $311 099 616 | 1 146 066 | 1,52% | Acciones |
| Clearbridge Investments, LLC | $276 424 438 | 1 018 325 | 1,35% | Acciones |
| RTW INVESTMENTS, LP | $271 450 000 | 1 000 000 | 1,32% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $249 356 413 | 918 609 | 1,22% | Acciones |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197 243 187 | 726 628 | 0,96% | Acciones |
| ARK Investment Management LLC | $186 989 592 | 688 855 | 0,91% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $174 716 892 | 643 643 | 0,85% | Acciones |
| Chevy Chase Trust Holdings, LLC | $162 830 912 | 599 856 | 0,79% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160 551 817 | 591 460 | 0,78% | Acciones |
| FIRST TRUST ADVISORS LP | $138 768 953 | 511 214 | 0,68% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $135 199 396 | 498 064 | 0,66% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $129 951 802 | 478 732 | 0,63% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $125 949 543 | 463 988 | 0,61% | Acciones |
| Avala Global LP | $124 867 000 | 460 000 | 0,61% | Acciones |
| JANE STREET GROUP, LLC | $120 781 406 | 444 949 | 0,59% | Acciones |
| Robeco Institutional Asset Management B.V. | $110 918 814 | 408 616 | 0,54% | Acciones |
| VIKING GLOBAL INVESTORS LP | $106 053 886 | 390 694 | 0,52% | Acciones |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $105 594 050 | 389 000 | 0,51% | Acciones |
| Driehaus Capital Management LLC | $104 202 054 | 383 872 | 0,51% | Acciones |
| GOLDMAN SACHS GROUP INC | $103 829 625 | 382 500 | 0,51% | Opción de compra |
| Swiss National Bank | $103 096 710 | 379 800 | 0,50% | Acciones |
| JANE STREET GROUP, LLC | $100 300 775 | 369 500 | 0,49% | Opción de venta |
| Amova Asset Management Americas, Inc. | $99 926 238 | 368 066 | 0,49% | Acciones |
| Man Group plc | $97 455 436 | 359 018 | 0,48% | Acciones |
| California Public Employees Retirement System | $93 399 430 | 344 076 | 0,46% | Acciones |
| Squarepoint Ops LLC | $91 279 949 | 336 268 | 0,45% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $84 486 098 | 311 240 | 0,41% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82 819 395 | 305 100 | 0,40% | Opción de venta |
| DIMENSIONAL FUND ADVISORS LP | $82 812 880 | 305 076 | 0,40% | Acciones |
| COATUE MANAGEMENT LLC | $80 563 646 | 296 790 | 0,39% | Acciones |
| Capital Impact Advisors, LLC | $80 411 091 | 296 228 | 0,39% | Acciones |
| AMERIPRISE FINANCIAL INC | $75 314 616 | 277 451 | 0,37% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $74 936 546 | 276 064 | 0,37% | Acciones |
| CITADEL ADVISORS LLC | $72 099 020 | 265 607 | 0,35% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $71 251 553 | 262 485 | 0,35% | Acciones |
| ORBIMED ADVISORS LLC | $71 119 900 | 262 000 | 0,35% | Acciones |
| TWO SIGMA ADVISERS, LP | $70 490 993 | 307 700 | 0,34% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $70 377 484 | 259 265 | 0,34% | Acciones |
| PointState Capital LP | $70 037 357 | 258 012 | 0,34% | Acciones |
| Point72 Asset Management, L.P. | $68 655 134 | 252 920 | 0,33% | Acciones |
| Assenagon Asset Management S.A. | $68 098 390 | 250 869 | 0,33% | Acciones |
| BlackRock, Inc. | $61 219 847 | 225 529 | 0,30% | Acciones |
| National Pension Service | $61 139 769 | 225 234 | 0,30% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $58 410 679 | 292 068 | 0,28% | Acciones |
| TD Asset Management Inc | $56 207 523 | 207 064 | 0,27% | Acciones |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | $55 932 001 | 206 049 | 0,27% | Acciones |
| CITADEL ADVISORS LLC | $54 561 450 | 201 000 | 0,27% | Opción de venta |
| Artemis Investment Management LLP | $54 313 616 | 200 087 | 0,26% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $52 978 986 | 195 170 | 0,26% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $50 424 281 | 185 759 | 0,25% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $49 380 284 | 181 913 | 0,24% | Acciones |
| Eversept Partners, LP | $47 722 810 | 175 807 | 0,23% | Acciones |
| Erste Asset Management GmbH | $47 112 625 | 173 011 | 0,23% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $47 109 261 | 173 547 | 0,23% | Acciones |
| RHUMBLINE ADVISERS | $46 531 361 | 171 418 | 0,23% | Acciones |
| JENNISON ASSOCIATES LLC | $46 107 586 | 169 857 | 0,22% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $45 830 804 | 168 837 | 0,22% | Acciones |
| LPL Financial LLC | $45 315 137 | 166 937 | 0,22% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44 300 640 | 163 200 | 0,22% | Opción de compra |
| Qube Research & Technologies Ltd | $43 724 895 | 161 079 | 0,21% | Acciones |
| IEQ CAPITAL, LLC | $40 419 133 | 148 901 | 0,20% | Acciones |
| Ensign Peak Advisors, Inc | $39 971 827 | 147 253 | 0,19% | Acciones |
| JANE STREET GROUP, LLC | $39 930 295 | 147 100 | 0,19% | Opción de compra |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $39 561 022 | 197 815 | 0,19% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $39 068 984 | 143 927 | 0,19% | Acciones |
| ROYAL BANK OF CANADA | $38 963 000 | 143 535 | 0,19% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $38 891 999 | 143 275 | 0,19% | Acciones |
| HighTower Advisors, LLC | $38 255 720 | 140 931 | 0,19% | Acciones |
| Caption Management, LLC | $38 003 000 | 140 000 | 0,19% | Opción de compra |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $37 658 258 | 138 730 | 0,18% | Acciones |
| Rokos Capital Management LLP | $37 210 859 | 137 049 | 0,18% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $36 308 609 | 133 758 | 0,18% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $35 775 481 | 131 794 | 0,17% | Acciones |
| MAPLELANE CAPITAL, LLC | $34 338 425 | 126 500 | 0,17% | Opción de compra |
| CANADA PENSION PLAN INVESTMENT BOARD | $33 741 235 | 124 300 | 0,16% | Acciones |
| BANK OF AMERICA CORP /DE/ | $32 343 539 | 119 151 | 0,16% | Acciones |
| Davern Capital Partners, LP | $32 295 764 | 118 975 | 0,16% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $32 267 262 | 118 870 | 0,16% | Acciones |
| ThornTree Capital Partners LP | $31 493 900 | 116 021 | 0,15% | Acciones |
| CITADEL ADVISORS LLC | $30 918 155 | 113 900 | 0,15% | Opción de compra |
| MARSHALL WACE, LLP | $30 550 069 | 112 544 | 0,15% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $30 538 398 | 112 501 | 0,15% | Acciones |
| UBS Group AG | $29 990 339 | 110 482 | 0,15% | Acciones |
| Science & Technology Partners, L.P. | $29 826 926 | 109 880 | 0,15% | Acciones |
| AVIVA PLC | $29 381 205 | 108 238 | 0,14% | Acciones |
Informantes de la empresa 21 insiders · 1 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 de enero de 2023 A | 24 091 | 0 | 0 | $0 |
| Rowan E Chapman | Consejero | 15 de julio de 2026 S | 4 663 | 0 | 3 | $-1 138 859 |
| Eric H Rubin | Consejero | 26 de junio de 2026 A | 2 204 | 0 | 0 | $0 |
| Monica Bertagnolli | Consejero | 26 de junio de 2026 A | 7 020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Consejero | 26 de junio de 2026 A | 7 852 | 0 | 1 | $-651 646 |
| Roy D. Baynes | Consejero | 26 de junio de 2026 A | 20 158 | 0 | 0 | $0 |
| Thomas J. Lynch Jr. | Consejero | 26 de junio de 2026 A | 1 905 | 0 | 0 | $0 |
| Herm Rosenman | Consejero | 26 de junio de 2026 A | 5 927 | 0 | 5 | $-15 143 996 |
| ROELOF BOTHA ("RB") | Consejero | 26 de junio de 2026 A | 4 585 | 0 | 6 | $-17 184 060 |
| Dr. James I. Healy | Consejero | 25 de abril de 2025 A | 46 260 | 0 | 0 | $0 |
| Todd C Cozzens | Consejero | 25 de mayo de 2022 M | 15 813 | 0 | 0 | $0 |
| John Steuart | Consejero | 16 de mayo de 2019 M | 7 278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Consejero | 16 de mayo de 2019 M | 52 009 | 0 | 0 | $0 |
| Jonathan Sheena | — | 10 de agosto de 2026 S | 230 464 | 0 | 41 | $-7 235 616 |
| Matthew Rabinowitz | — | 7 de agosto de 2026 S | 2 000 | 0 | 25 | $-23 012 521 |
| Michael Burkes Brophy | — | 4 de agosto de 2026 S | 51 637 | 0 | 7 | $-1 498 665 |
| John Fesko | — | 3 de agosto de 2026 S | 183 774 | 0 | 3 | $-519 299 |
| Solomon Moshkevich | — | 3 de agosto de 2026 S | 129 019 | 0 | 16 | $-3 185 170 |
| Daniel Rabinowitz | — | 3 de agosto de 2026 S | 170 073 | 0 | 19 | $-13 604 463 |
| Steven Leonard Chapman | — | 3 de agosto de 2026 S | 99 897 | 0 | 13 | $-3 322 018 |
| Ruth Williams Brinkley | — | 24 de abril de 2026 A | 5 475 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 presentaciones | 13 de febrero de 2020 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 113 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EKG · First Trust Exchange-Traded Fund II | 4,66% | 483 NS | 30 de junio de 2026 | N-PORT |
| GNOM · Global X Funds | 4,15% | 10 370 NS | 31 de mayo de 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,07% | 243 718 NS | 30 de abril de 2026 | N-PORT |
| FBT · First Trust Exchange-Traded Fund | 3,79% | 393 185 NS | 30 de junio de 2026 | N-PORT |
| IBB · iShares Trust | 3,13% | 1 021 038 SH | 21 de agosto de 2026 | Diario |
| WUGI · INVESTMENT MANAGERS SERIES TRUST II | 2,42% | 3 222 NS | 30 de junio de 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2,35% | 3 142 NS | 30 de abril de 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,28% | 83 154 SH | 21 de agosto de 2026 | Diario |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,17% | 5 611 NS | 30 de abril de 2026 | N-PORT |
| FFOX · FundX Investment Trust | 2,03% | 17 937 NS | 30 de junio de 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,72% | 7 656 NS | 31 de mayo de 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,57% | 13 843 NS | 30 de abril de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,43% | 2 615 NS | 31 de mayo de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 56 770 NS | 30 de abril de 2026 | N-PORT |
| IWP · iShares Trust | 1,25% | 787 080 SH | 21 de agosto de 2026 | Diario |
| ARKK · ARK ETF Trust | 1,17% | 369 404 NS | 30 de abril de 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 2 954 NS | 30 de abril de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1 802 288 SH | 19 de agosto de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,98% | 24 696 NS | 30 de abril de 2026 | N-PORT |
| TAX · EA Series Trust | 0,92% | 1 046 NS | 29 de mayo de 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 396 SH | 21 de agosto de 2026 | Diario |
| IYH · iShares Trust | 0,69% | 81 515 SH | 21 de agosto de 2026 | Diario |
| HQGO · Lattice Strategies Trust | 0,68% | 1 580 NS | 30 de abril de 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,66% | 1 989 NS | 31 de mayo de 2026 | N-PORT |
| IMCG · iShares Trust | 0,60% | 75 096 SH | 21 de agosto de 2026 | Diario |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,56% | 54 813 NS | 30 de abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,54% | 404 713 SH | 19 de agosto de 2026 | Diario |
| CANC · Tema ETF Trust | 0,54% | 4 238 NS | 31 de mayo de 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,48% | 60 571 NS | 31 de mayo de 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 29 486 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1 643 356 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3 120 454 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 60 581 NS | 30 de abril de 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,40% | 41 NS | 30 de abril de 2026 | N-PORT |
| CVMC · Morgan Stanley ETF Trust | 0,37% | 1 390 NS | 30 de junio de 2026 | N-PORT |
| IWR · iShares Trust | 0,32% | 555 868 SH | 21 de agosto de 2026 | Diario |
| IMCB · iShares Trust | 0,30% | 15 799 SH | 21 de agosto de 2026 | Diario |
| SIZE · iShares Trust | 0,30% | 4 071 SH | 21 de agosto de 2026 | Diario |
| EUSA · iShares, Inc. | 0,29% | 17 533 SH | 21 de agosto de 2026 | Diario |
| ROUS · Lattice Strategies Trust | 0,28% | 8 068 NS | 30 de abril de 2026 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0,26% | 178 926 NS | 31 de mayo de 2026 | N-PORT |
| FTQI · First Trust Exchange-Traded Fund VI | 0,25% | 8 600 NS | 30 de junio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,25% | 21 762 SH | 21 de agosto de 2026 | Diario |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,24% | 1 020 NS | 31 de mayo de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 5 580 NS | 30 de abril de 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,24% | 558 NS | 31 de mayo de 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 23 988 NS | 30 de abril de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,22% | 103 NS | 31 de mayo de 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,22% | 2 049 NS | 31 de mayo de 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,20% | 15 978 NS | 31 de mayo de 2026 | N-PORT |